Evan Wuthrick Selected Research

Evan Wuthrick Research Topics

Disease

8	Neoplasms (Cancer) 01/2022 - 04/2015
4	Melanoma (Melanoma, Malignant) 01/2022 - 01/2019
4	Adenocarcinoma 12/2018 - 04/2015
3	Brain Neoplasms (Brain Tumor) 01/2022 - 04/2016
3	Rectal Neoplasms (Rectal Cancer) 01/2020 - 12/2017
3	Pancreatic Neoplasms (Pancreatic Cancer) 12/2018 - 04/2015
2	Neoplasm Metastasis (Metastasis) 03/2024 - 12/2017
2	Merkel Cell Carcinoma 01/2022 - 04/2016
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 04/2018
1	Diarrhea 01/2020
1	Esophageal Neoplasms (Esophageal Cancer) 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Colonic Neoplasms (Colon Cancer) 04/2018
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2018
1	Breast Neoplasms (Breast Cancer) 04/2016
1	Temporal Lobe Epilepsy 04/2016
1	Glioma (Gliomas) 04/2016
1	Infections 04/2016
1	Multiple Myeloma 04/2016
1	Parathyroid Neoplasms (Parathyroid Neoplasm) 04/2016
1	Prostatic Neoplasms (Prostate Cancer) 04/2016
1	Thyroid Neoplasms (Thyroid Cancer) 04/2016
1	Tuberculosis (Tuberculoses) 04/2016

Drug/Important Bio-Agent (IBA)

3	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 04/2015
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 01/2020
2	trametinibIBA 01/2022 - 01/2020
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2018 - 04/2016
1	NivolumabIBA 01/2022
1	N- methyl- N- (1- methyl- 4- pyrrolidino- 2- butynyl)acetamide (BM 5)IBA 01/2022
1	Death Domain ReceptorsIBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	IpilimumabIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2019
1	Sorafenib (BAY 43-9006)FDA Link 01/2019
1	VemurafenibIBA 04/2018
1	Docetaxel (Taxotere)FDA Link 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	Bevacizumab (Avastin)FDA Link 01/2018
1	MicroRNAs (MicroRNA)IBA 09/2017
1	plecanatideIBA 01/2017
1	linaclotideIBA 01/2017
1	Hormones (Hormone)IBA 01/2017
1	ErbB Receptors (EGF Receptor)IBA 04/2016
1	AcidsIBA 04/2016
1	AerosolsIBA 04/2016
1	Choline (Choline Chloride)IBA 04/2016
1	Ciprofloxacin (Cipro)FDA LinkGeneric 04/2016
1	Yttrium-90IBA 04/2016
1	Dihydroxyphenylalanine (Dopa)IBA 04/2016
1	Liposomes (Liposome)IBA 04/2016
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2016
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 04/2016
1	Dictyostelium severin protein (severin)IBA 04/2016
1	23-seleno-25-homotaurocholic acidIBA 04/2016
1	gallium 68 PSMA-11IBA 04/2016
1	Methionine (L-Methionine)FDA Link 04/2016
1	radium Ra 223 dichlorideIBA 04/2016
1	5-(2-fluoroethyl) 2,4- diethyl- 3- (ethylsulfanylcarbonyl)- 6- phenylpyridine- 5- carboxylateIBA 04/2016
1	fluoromethylcholineIBA 04/2016
1	fluorocholineIBA 04/2016
1	SolutionsIBA 04/2016
1	multidrug resistance-associated protein 1IBA 04/2016
1	Verapamil (Calan)FDA LinkGeneric 04/2016
1	melanin-concentrating hormone receptorIBA 04/2016
1	N,N'- bis(2- hydroxy- 5- (ethylene- beta- carboxy)benzyl)ethylenediamine N,N'-diacetic acidIBA 04/2016
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 04/2016
1	lipoarabinomannan (LAM)IBA 04/2016
1	Leucovorin (Folinic Acid)FDA Link 04/2015
1	Irinotecan (Camptosar)FDA LinkGeneric 04/2015
1	Gemcitabine FDA Link 04/2015
1	folfirinoxIBA 04/2015
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2015

Therapy/Procedure

8	Radiotherapy 03/2024 - 01/2018
7	Therapeutics 01/2022 - 01/2017
4	Adjuvant Chemotherapy 01/2020 - 12/2017
4	Neoadjuvant Therapy 01/2020 - 12/2017
2	Lymph Node Excision (Lymph Node Dissection) 09/2021 - 01/2021